SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-057869
Filing Date
2014-08-07
Accepted
2014-08-07 07:53:39
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-14231_110q.htm 10-Q 472241
2 EX-31.1 a14-14231_1ex31d1.htm EX-31.1 11774
3 EX-31.2 a14-14231_1ex31d2.htm EX-31.2 11766
4 EX-32.1 a14-14231_1ex32d1.htm EX-32.1 5609
5 EX-32.2 a14-14231_1ex32d2.htm EX-32.2 5628
  Complete submission text file 0001104659-14-057869.txt   4121005

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20140630.xml EX-101.INS 370728
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kpti-20140630.xsd EX-101.SCH 54597
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kpti-20140630_cal.xml EX-101.CAL 32857
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kpti-20140630_def.xml EX-101.DEF 241915
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT kpti-20140630_lab.xml EX-101.LAB 889210
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kpti-20140630_pre.xml EX-101.PRE 427355
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 141021779
SIC: 2834 Pharmaceutical Preparations